A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response. (2020)
Attributed to:
OxCD3: Oxford Centre for Drug Delivery Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejps.2020.105456
PubMed Identifier: 32653563
Publication URI: http://europepmc.org/abstract/MED/32653563
Type: Journal Article/Review
Volume: 152
Parent Publication: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 0928-0987